Literature DB >> 10396790

The quantification of mortality resulting from the regular use of illicit opiates.

G K Hulse1, D R English, E Milne, C D Holman.   

Abstract

UNLABELLED: AIMS/
DESIGN: Estimates of mortality associated with illicit opiate use provide useful information to those directing and monitoring local, national and international policies and programmes. Most studies investigating the association have, however, been small with imprecise estimates of increased mortality. The current study combines data from a number of international studies in a meta-analysis to estimate more precisely mortality associated with illicit opiate use. Because HIV infection among injecting drug users differs dramatically between countries and localities, we excluded studies where AIDS was a major contributor to mortality. Studies were included only where AIDS-specific mortality accounted for less than 2% of total mortality.
FINDINGS: Our results show a mortality rate for people regularly using illicit opiates, which is more than 13 times greater than that observed for the general community. It is estimated that 9.4% of total mortality in Australians aged 15-39 years of age can be attributed to regular use of illicit opiates. Application of this aetiological fraction to Australian mortality data for 1992 indicate that approximately 401 male and 161 female deaths occurred as a result of opiate use. This represents some 15,429 and 6261 person-years of life lost (to age 70) for males and females, respectively.
CONCLUSIONS: The mortality rate for illicit opiate users is approximately 13 times greater than for the general population. The large number of years of life lost is reflective of the relatively young population (15-39 years of age) in which opiate-related mortality occurs. Relative risk estimates can also be applied to data on the prevalence of illicit opiate use in other countries to produce locally based aetiological fractions and estimates of person-years of life lost.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10396790     DOI: 10.1046/j.1360-0443.1999.9422216.x

Source DB:  PubMed          Journal:  Addiction        ISSN: 0965-2140            Impact factor:   6.526


  59 in total

1.  Injecting drug use in Brighton, Liverpool, and London: best estimates of prevalence and coverage of public health indicators.

Authors:  Matthew Hickman; Vanessa Higgins; Vivian Hope; Mark Bellis; Kate Tilling; Angeline Walker; John Henry
Journal:  J Epidemiol Community Health       Date:  2004-09       Impact factor: 3.710

2.  Policing and risk of overdose mortality in urban neighborhoods.

Authors:  Amy S B Bohnert; Arijit Nandi; Melissa Tracy; Magdalena Cerdá; Kenneth J Tardiff; David Vlahov; Sandro Galea
Journal:  Drug Alcohol Depend       Date:  2010-08-19       Impact factor: 4.492

3.  Mu opioid receptor A118G polymorphism in association with striatal opioid neuropeptide gene expression in heroin abusers.

Authors:  Katarina Drakenberg; Andrej Nikoshkov; Monika Cs Horváth; Pernilla Fagergren; Anna Gharibyan; Kati Saarelainen; Sadia Rahman; Ingrid Nylander; Georgy Bakalkin; Jovan Rajs; Eva Keller; Yasmin L Hurd
Journal:  Proc Natl Acad Sci U S A       Date:  2006-05-08       Impact factor: 11.205

4.  Risk of mortality during four years after substance detoxification in urban adults.

Authors:  Richard Saitz; Jessie Gaeta; Debbie M Cheng; Jessica M Richardson; Mary Jo Larson; Jeffrey H Samet
Journal:  J Urban Health       Date:  2007-03       Impact factor: 3.671

5.  A comparative study of mortality among Puerto Rican injection drug users in East Harlem, New York, and Bayamon, Puerto Rico.

Authors:  Hector Manuel Colon; Sherry Deren; Rafaela Rivera Robles; Sung-Yeon Kang; Myrna Cabassa; Hardeo Sahai
Journal:  J Urban Health       Date:  2006-11       Impact factor: 3.671

6.  Factors associated with injection cessation, relapse and initiation in a community-based cohort of injection drug users in Chennai, India.

Authors:  Shruti H Mehta; Darshan Sudarshi; Aylur K Srikrishnan; David D Celentano; Canjeevaram K Vasudevan; Santhanam Anand; Muniratnam Suresh Kumar; Carl Latkin; Suniti Solomon; Sunil S Solomon
Journal:  Addiction       Date:  2011-10-12       Impact factor: 6.526

7.  Buprenorphine retention in primary care.

Authors:  Michael D Stein; Patricia Cioe; Peter D Friedmann
Journal:  J Gen Intern Med       Date:  2005-11       Impact factor: 5.128

8.  Craving predicts opioid use in opioid-dependent patients initiating buprenorphine treatment: a longitudinal study.

Authors:  Judith I Tsui; Bradley J Anderson; David R Strong; Michael D Stein
Journal:  Am J Drug Alcohol Abuse       Date:  2014-02-12       Impact factor: 3.829

9.  Are non-fatal opioid overdoses misclassified suicide attempts? Comparing the associated correlates.

Authors:  Elizabeth Maloney; Louisa Degenhardt; Shane Darke; Elliot C Nelson
Journal:  Addict Behav       Date:  2009-05-03       Impact factor: 3.913

10.  Number of addictive substances used related to increased risk of unnatural death: a combined medico-legal and case-record study.

Authors:  Louise Brådvik; Mats Berglund; Arne Frank; Anna Lindgren; Peter Löwenhielm
Journal:  BMC Psychiatry       Date:  2009-08-04       Impact factor: 3.630

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.